Academic Spotlight: Dr Emmanuel Adukwu

Posted on

In this Academic Spotlight we asked Dr Emmanuel Adukwu, Deputy Head of Department for Applied Sciences, a few questions about the research he is involved with at UWE Bristol.

Tell us about your background and how you became interested in your research area?

I graduated with a degree in Biomedical Sciences at Coventry University. During my final year, I chose a project which started my interest in the role nature plays in modulating and promoting health. This subsequently led to my postgraduate study at Manchester Metropolitan University working with Professor Valerie Edwards-Jones (emeritus) where I carried out an industry-funded masters by research (MRes) investigating the role of essential oils as antimicrobial agents and a research assistantship project working on a human volunteer trial to develop a novel topical antimicrobial agent.

After my MRes, I moved into industry working with ICON Plc, the world’s leader in clinical research. I worked as a clinical trials coordinator, setting up and running several high-profile large-scale studies for the major global biopharma organisations. I decided to pursue a PhD at the University of Northampton funded by Northamptonshire NHS Trust working with Professor Carol Phillips. My PhD project was informed by the experiences I had during my BSc (final year project) and MRes degrees considering I had several offers and needed to make a firm decision.. My project investigated community acquired infections which was a significant health conundrum at the time and continues to contribute to the infection burden in health settings globally.

Tell us more about your research and research projects, are there any particular projects you want to highlight?

My research explores the role that natural compounds can play in preventing or controlling infections caused by pathogenic bacteria and fungi. In my group, we have carried out investigations into the potential of plant-based compounds in reducing significant healthcare pathogens such as Staphylococcus aureus (associated with many infections in humans), Acinetobacter baumannii which is considered by the CDC as a serious public health threat as it is known to be resistant to multiple antibiotics and is an organism linked with major amputations.

Recently we have focused a lot of work on a newly discovered fungus called Candida auris. This is a particularly interesting organism as it is also known to be resistant to current antifungal treatments, spreads easily in hospital settings and can cause serious infections. According to the CDC, 1 in 3 patients who are affected with invasive Candida auris infection die. We have shown that using plant-based compounds, we can limit the growth and spread of this emerging threat and hope to develop innovative strategies that can be utilised in healthcare settings.

Some ongoing projects worth mentioning include two PhD research projects with my students Obiageli Okolie and Uzoma Igwe who are carrying out research focused on preventing the spread of antimicrobial resistance, preventing and controlling infections at national level with a focus on the healthcare system in Nigeria. These two projects have involved leading KOLs and health experts across the country and would go a long way in informing policy.

If you are a fan of or connoisseur of teas, keep an eye out on our recently commenced project funded via the partnership PhD scheme between Pukka Herbs and UWE bristol where we aim to explore some of the benefits of some herbal tea blends on human health and wellbeing.

Give us a brief description of how your academic expertise could be practically applied for a business partner or for external collaboration?

In terms of research, my work would interest organisations and potential collaborators interested in developing antimicrobials products or therapies (antibacterial, antifungals, disinfectants etc) to reduce infections in humans and animals. We have previously carried out work investigating survival of clinical pathogens on medical devices in particular swab transport systems. The knowledge and expertise developed this these projects can be of benefit to companies interested in developing special media for these important transport systems for healthcare and other relevant settings e.g. food, animal etc.

In addition, I have extensive expertise developing initiatives and solutions to address/embed inclusivity within teams and organisations. With many forward-looking organisations, inclusivity and diversity is key to growth and I am happy to collaborate or engage with organisations looking at meaningful organisational change in this area.

You can get in touch with Dr Emmanuel Adukwu through his LinkedIn profile

Back to top